Diabetes type 2: relationships between lysosomal exocytosis of circulating normal-sized platelets and in vitro ɑ-thrombin-evoked platelet responses

References

• Heemskerk JWM, Mattheij NJA, Cosemans JMEM. Platelet-based coagulation: different populations, different functions. J Thromb Haemost. 2013;11(1):2–16.
   PubMed Web of Science ®Google Scholar
• Mazepa M, Hoffman M, Monroe D. Superactivated platelets: thrombus regulators, thrombin generators, and potential clinical targets. Arterioscler Thromb Vasc Biol. 2013;33(8):1747–1752.
   PubMed Web of Science ®Google Scholar
• Dale GL. Procoagulant platelets: further details but many more questions. Arterioscler Thromb Vasc Biol. 2017;37(9):1596–1597.
   PubMed Web of Science ®Google Scholar
• Södergren AL, Ramström S. Platelet subpopulations remain despite strong dual agonist stimulation and can be characterised using a novel six-colour flow cytometry protocol. Sci Rep. 2018;8:1441.
   PubMed Web of Science ®Google Scholar
• Panteleev MA, Ananyeva NM, Greco NJ, et al. Two subpopulations of thrombin-activated platelets differ in their binding of the components of the intrinsic factor X-activating complex. J Thromb Haemost. 2005;3(11):2545–2553.
   PubMed Web of Science ®Google Scholar
• Bevers EM, Comfurius P, van Rijn JL, et al. Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur J Biochem. 1982;122(2):429–436.
   PubMedGoogle Scholar
• Järemo P. Computerised method for recording platelet density distribution. Eur J Haematol. 1995;54(5):304–309.
   PubMed Web of Science ®Google Scholar
• Milovanovic M, Lysen J, Ramström S, et al. Identification of low-density platelet populations with increased reactivity and elevated alpha-granule content. Thromb Res. 2003;111(1-2):75–80.
   PubMed Web of Science ®Google Scholar
• Milovanovic M, Lotfi K, Lindahl TL, et al. Platelet density subpopulations in essential thrombocythemia and healthy volunteers. Pathophysiol Haemost Thromb. 2010;37(1):35–42.
   PubMedGoogle Scholar
• Corash L, Costa JL, Shafer B, et al. Heterogeneity of human whole blood platelet subpopulations. III. Density-dependent differences in subcellular constituents. Blood. 1984;64(1):185–193.
   PubMed Web of Science ®Google Scholar
• Chamberlain KG, Penington DG. Monoamine oxidase and other mitochondrial enzymes in density subpopulations of human platelets. Thromb Haemost. 1988;59(1):29–33.
   PubMed Web of Science ®Google Scholar
• Chamberlain KG, Seth P, Jones MK, et al. Subcellular composition of platelet density subpopulations prepared using continuous Percoll gradients. Br J Haematol. 1989;72(2):199–207.
   PubMed Web of Science ®Google Scholar
• Prodan CI, Stoner JA, Cowan LD, et al. Higher coated-platelet levels are associated with stroke recurrence following non-lacunar brain infarction. J Cereb Blood Flow Metab. 2013;33(2):287–292.
   PubMed Web of Science ®Google Scholar
• Prodan CI, Ross ED, Stoner JA, et al. Coated-platelet levels and progression from mild cognitive impairment to Alzheimer disease. Neurology. 2011;76(3):247–252.
   PubMed Web of Science ®Google Scholar
• Wong CK, Namdarian B, Chua J, et al. Levels of a subpopulation of platelets, but not circulating endothelial cells, predict early treatment failure in prostate cancer patients after prostatectomy. Br J Cancer. 2012;107(9):1564–1573.
   PubMed Web of Science ®Google Scholar
• Järemo P, Milovanovic M, Nilsson S, et al. Platelet heterogeneity and Alzheimer´s disease: low density platelets populations demonstrate low in vivo activity. Platelets. 2012;23(2):116–120.
   PubMed Web of Science ®Google Scholar
• Martin JF, Plumb J, Kilbey RS, et al. Changes in volume and density of platelets in myocardial infarction. Br Med J (Clin Res Ed). 1983;287(6390):456–459.
   PubMedGoogle Scholar
• Järemo P, Hansson G, Nilsson O. Elevated inflammatory parameters are associated with lower platelet density in acute myocardial infarctions with ST-elevation. Thromb Res. 2000;100(6):471–478.
   PubMed Web of Science ®Google Scholar
• Järemo P, Sandberg-Gertzen H. Platelet density and size in inflammatory bowel disease. Thromb Haemost. 1996;5:560–561.
   Google Scholar
• Järemo P, Lindahl TL, Lennmarken C, et al. The use of platelet density and volume measurements to estimate the severity of pre-eclampsia. Eur J Clin Invest. 2000;30(12):1113–1118.
   PubMed Web of Science ®Google Scholar
• Santilli F, Simeone P, Liani R, et al. Platelets and diabetes mellitus. Prostaglandins Other Lipid Mediat. 2015;120:28–39.
   PubMed Web of Science ®Google Scholar
• Ferroni P, Basili S, Falco A, et al. Platelet activation in type 2 diabetes mellitus. J Thromb Haemost. 2004;2(8):1282–1291.
   PubMed Web of Science ®Google Scholar
• Järemo P, Milovanovic M, Lindahl TL, et al. Elevated platelet density and enhanced platelet reactivity in stable angina pectoris complicated by diabetes mellitus type II. Thromb Res. 2009;124(3):373–374.
   PubMed Web of Science ®Google Scholar
• Cohen Z, Gonzales RF, Davis-Gorman GF, et al. Thrombin activity and platelet microparticle formation are increased in type 2 diabetic platelets: a potential correlation with caspase activation. Thromb Res. 2002;107(5):217–221.
   PubMed Web of Science ®Google Scholar
• Bethel MA, Harrison P, Sourij H, et al. Randomized controlled trial comparing impact on platelet reactivity of twice-daily with once-daily aspirin in people with type 2 diabetes. Diabet Med. 2016;33(2):224–230.
   PubMed Web of Science ®Google Scholar
• Edvardsson M, Oweling M, Järemo P. Small procoagulant platelets in diabetes type 2. Thromb Res. 2020;195:1–7.
   PubMed Web of Science ®Google Scholar
• Milovanovic M, Nilsson S, Winblad B, et al. Inverse relationship between erythrocyte size and platelet reactivity in elderly. Platelets. 2016;24:1–5.
   Google Scholar
• Järemo P, Lindahl TL, Fransson SG, et al. Individual variations of platelet inhibition after loading doses of clopidogrel. J Int Med. 2002;52:233–238.
   Google Scholar